StockData
ALX Oncology Holdings Inc logo

ALX Oncology Holdings Inc (ALXO) stock

ALXONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.97−0.03 (-3.47%)

Close on Nov 18, 2026Market cap $134.14MP/E –Yield –

ALX Oncology market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

ALX Oncology's market cap was $154.80M on Nov 11, 2026, against $73.40M a year earlier. Over the last 5 years it ranged from $22.16M to $870.05M, with a median of $262.61M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$154.80M+155.7%
2025Dec 31, 2025$60.54M-31.3%
2024Dec 31, 2024$88.08M-85.6%
2023Dec 29, 2023$612.75M+33.4%
2022Dec 30, 2022$459.23M-47.2%
2021Dec 31, 2021$870.05M-72.8%
2020Dec 31, 2020$3.20B–

More ALX Oncology figures

See a number that looks wrong?